{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:08:31Z","timestamp":1791439711789,"version":"4.3.3"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","issue":"05\/06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mifepristone medication abortion was first approved in China and France more than 30 years ago and is now used in more than 60 countries worldwide. It is a highly safe and effective method that has the potential to increase population access to abortion in early pregnancy, closer to home. In both Canada and the United States, the initial regulations for distribution, prescribing, and dispensing of mifepristone were highly restricted. However, in Canada, where mifepristone was made available in 2017, most restrictions on the medication were removed in the first year of its availability. The Canadian regulation of mifepristone as a normal prescription makes access possible in community primary care through a physician or nurse practitioner prescription, which any pharmacist can dispense. In this approach, people decide when and where to take their medication. We explore how policy-maker-engaged research advanced reproductive health policy and facilitated this rapid change in Canada. We discuss the implications of these policy advances for self-management of abortion and demonstrate how in Canada patients \u201cself-manage\u201d components of the abortion process within a supportive health care system.<\/jats:p>","DOI":"10.1055\/s-0042-1760213","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T23:39:55Z","timestamp":1675726795000},"page":"268-276","source":"Crossref","is-referenced-by-count":6,"title":["Advancing Reproductive Health through Policy-Engaged Research in Abortion Care"],"prefix":"10.1055","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-6592","authenticated-orcid":false,"given":"Sarah B.","family":"Munro","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-1364","authenticated-orcid":false,"given":"Sheila","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-9076","authenticated-orcid":false,"given":"Edith R.","family":"Guilbert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproduction, Laval University, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V.","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"ref1","volume-title":"State of the World Population: Seeing the Unseen - The Case for Action in the Neglected Crisis of Unintended Pregnancy","author":"United Nations Population Fund","year":"2022"},{"issue":"02","key":"ref5","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","author":"R Kulier","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2012.10.027","article-title":"A review of evidence for safe abortion care","volume":"88","author":"N Kapp","year":"2013","journal-title":"Contraception"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200\u2009mg and misoprostol: a systematic review","volume":"87","author":"E G Raymond","year":"2013","journal-title":"Contraception"},{"issue":"07","key":"ref8","first-page":"CD011242","article-title":"Doctors or mid-level providers for abortion","volume":"2015","author":"S Barnard","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2015.06.016","article-title":"Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data","volume":"92","author":"K Cleland","year":"2015","journal-title":"Contraception"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2015.06.018","article-title":"Outpatient medical abortion is safe and effective through 70 days gestation","volume":"92","author":"D Abbas","year":"2015","journal-title":"Contraception"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"M J Chen","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2105\/AJPH.2012.301197","article-title":"Abortion law around the world: progress and pushback","volume":"103","author":"L Finer","year":"2013","journal-title":"Am J Public Health"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMsb1612526","article-title":"Sixteen years of overregulation: time to unburden Mifeprex","volume":"376","author":"E G Raymond","year":"2017","journal-title":"N Engl J Med"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"e2111852","DOI":"10.1001\/jamanetworkopen.2021.11852","article-title":"Factors associated with use of an online telemedicine service to access self-managed medical abortion in the US","volume":"4","author":"A RA Aiken","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"e2122320","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic","volume":"4","author":"U D Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.contraception.2021.03.019","article-title":"Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic","volume":"104","author":"E Chong","year":"2021","journal-title":"Contraception"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1370\/afm.2562","article-title":"Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study","volume":"18","author":"S Munro","year":"2020","journal-title":"Ann Fam Med"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMsa2109779","article-title":"Abortion safety and use with normally prescribed mifepristone in Canada","volume":"386","author":"L Schummers","year":"2022","journal-title":"N Engl J Med"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jogc.2022.02.088","article-title":"Mifepristone's effect on the abortion workforce and rural services in Ontario","volume":"44","author":"W V Norman","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13012-021-01144-w","article-title":"Pharmacist dispensing of the abortion pill in Canada: diffusion of innovation meets integrated knowledge translation","volume":"16","author":"S Munro","year":"2021","journal-title":"Implement Sci"},{"issue":"07","key":"ref35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1503\/cmaj.045019","article-title":"Effects of making emergency contraception available without a physician's prescription: a population-based study","volume":"172","author":"J A Soon","year":"2005","journal-title":"CMAJ"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/17151635211034534","article-title":"Enhancing access to contraception through pharmacist prescribing across Canada","volume":"154","author":"J A Soon","year":"2021","journal-title":"Can Pharm J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(20)31785-2","article-title":"Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial","volume":"396","author":"S T Cameron","year":"2020","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.1503\/cmaj.160581","article-title":"Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion","volume":"188","author":"W V Norman","year":"2016","journal-title":"CMAJ"},{"key":"ref40","first-page":"50","article-title":"Constitutional jurisdiction over health and health care services in Canada","volume":"3","author":"H Leeson","year":"2004","journal-title":"Gov Health Care Can Romanow Pap"},{"key":"ref41","first-page":"40","volume-title":"How do issues get on public policy agendas","author":"J W Kingdon","year":"1993"},{"key":"ref42","volume-title":"Agendas, Alternatives, and Public Policies","author":"J W Kingdon","year":"1984"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10728-008-0101-0","article-title":"Improving abortion access in Canada","volume":"18","author":"C Kaposy","year":"2010","journal-title":"Health Care Anal"},{"issue":"04","key":"ref44","first-page":"e209","article-title":"Abortion services in Canada: results of a 2012 national survey","volume":"62","author":"W V Norman","year":"2016","journal-title":"Can Fam Phys"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.wsif.2013.02.001","article-title":"Spatial disparities and travel to freestanding abortion clinics in Canada","volume":"38","author":"C Sethna","year":"2013","journal-title":"Womens Stud Int Forum"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1503\/cmaj.131320","article-title":"Medical abortion in Canada: behind the times","volume":"186","author":"S Dunn","year":"2014","journal-title":"CMAJ"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.4324\/9781315860725","volume-title":"The Abortion Debate in the United States and Canada: A Source book","author":"M Muldoon","year":"2021"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"e028443","DOI":"10.1136\/bmjopen-2018-028443","article-title":"Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol","volume":"9","author":"W V Norman","year":"2019","journal-title":"BMJ Open"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"e0227216","DOI":"10.1371\/journal.pone.0227216","article-title":"Leadership for success in transforming medical abortion policy in Canada","volume":"15","author":"B Dineley","year":"2020","journal-title":"PLoS One"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.contraception.2015.06.014","article-title":"Mifepristone by prescription: a dream in the United States but reality in Australia","volume":"92","author":"D Grossman","year":"2015","journal-title":"Contraception"},{"issue":"01","key":"ref56","first-page":"197","article-title":"Decriminalization and women's access to abortion in Australia","volume":"19","author":"B Baird","year":"2017","journal-title":"Health Hum Rights"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12913-016-1846-z","article-title":"Towards comprehensive early abortion service delivery in high income countries: insights for improving universal access to abortion in Australia","volume":"16","author":"A Dawson","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"e67023","DOI":"10.1371\/journal.pone.0067023","article-title":"Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS)","volume":"8","author":"W V Norman","year":"2013","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2022.03.020","article-title":"Provision of First-trimester Medication Abortion in 2019: Results from the Canadian Abortion Provider Survey","volume":"113","author":"M Ennis","year":"2022","journal-title":"Contraception"},{"issue":"05","key":"ref71","doi-asserted-by":"crossref","first-page":"e34302","DOI":"10.2196\/34302","article-title":"A virtual community of practice to support physician uptake of a novel abortion practice: mixed methods case study","volume":"24","author":"S Dunn","year":"2022","journal-title":"J Med Internet Res"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jogc.2019.10.037","article-title":"Barriers and facilitators to the implementation of first trimester medical abortion with mifepristone in the province of Qu\u00e9bec: a qualitative investigation","volume":"42","author":"M S Wagner","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13625187.2020.1743825","article-title":"Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation","volume":"25","author":"E Guilbert","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"07","key":"ref76","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.healthpol.2021.05.005","article-title":"The impact of COVID-19 on abortion access: insights from the European Union and the United Kingdom","volume":"125","author":"N Bojovic","year":"2021","journal-title":"Health Policy"},{"issue":"S 01","key":"ref77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1363\/46e0920","article-title":"Global developments in laws on induced abortion: 2008\u20132019","volume":"46","author":"L Remez","year":"2020","journal-title":"Int Perspect Sex Reprod Health"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ijgo.12509","article-title":"Access to knowledge and the global abortion policies database","volume":"142","author":"J N Erdman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmjsrh-2021-201243","article-title":"Are we prepared for change? The need for evidence on healthcare practitioner readiness for current and future trends in abortion provision in the UK","volume":"48","author":"R S French","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"ref80","first-page":"93","article-title":"Decriminalisation of abortion in New Zealand and Australia","volume":"132","author":"B R Johnson Jr","year":"2019","journal-title":"N Z Med J"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2021.12.003","article-title":"Integrating self-managed medication abortion with medical care","volume":"108","author":"M Dragoman","year":"2022","journal-title":"Contraception"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai'i during COVID-19: practical experience with multiple care delivery models","volume":"104","author":"C Kerestes","year":"2021","journal-title":"Contraception"},{"issue":"04","key":"ref84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic","volume":"47","author":"J J Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"issue":"09","key":"ref85","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"A Aiken","year":"2021","journal-title":"BJOG"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1760213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T23:44:14Z","timestamp":1675727054000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1760213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"journal-issue":{"issue":"05\/06","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1760213","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}